TY - JOUR
T1 - Measuring asymmetry in facial morphea via 3-dimensional stereophotogrammetry
AU - Abbas, Laila F.
AU - Joseph, Adrienne K.
AU - Day, Jennifer
AU - Cole, Naomi A.
AU - Hallac, Rami
AU - Derderian, Christopher
AU - Jacobe, Heidi T.
N1 - Funding Information:
Funding sources: Supported in part by the National Institutes of Health (grant numbers K23AR056303-5 and RO1 R01AR073516-01A1) and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number TL1TR001 and UL1TR000451, and the Nancy Taylor Foundation for Chronic Diseases , Inc. The content is solely the authors’ responsibility and does not necessarily represent the official views of UT-STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centers, the National Center for Research Resources, or the National Institutes of Health.
Funding Information:
Funding sources: Supported in part by the National Institutes of Health (grant numbers K23AR056303-5 and RO1 R01AR073516-01A1) and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number TL1TR001 and UL1TR000451, and the Nancy Taylor Foundation for Chronic Diseases, Inc. The content is solely the authors’ responsibility and does not necessarily represent the official views of UT-STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centers, the National Center for Research Resources, or the National Institutes of Health.
Publisher Copyright:
© 2022
PY - 2023/1
Y1 - 2023/1
N2 - Background: Objectively determining tissue loss in craniofacial morphea is challenging. However, 3-dimensional (3D) stereophotogrammetry is a noninvasive modality that may be a useful adjunct. Objective: To prospectively evaluate 3D stereophotogrammetry in the assessment of craniofacial linear morphea. Methods: Participants underwent clinical, quality-of-life, and 3D-stereophotogrammetry assessments. Traditional photographs and 3D-stereophotogrammetry images were rated as mild, moderate, or severe by 2 experts and 2 nonexperts. In addition, interrater and intrarater reliability (on delayed rescoring) were calculated. Results: Of 23 patients with craniofacial morphea, 3D stereophotogrammetry detected pathologic asymmetry in 14 (20.6%) patients. Providers rated patients as more severely affected when using 3D stereophotogrammetry versus when using traditional photographs (19% severe on 3D stereophotogrammetry vs 0% severe on traditional photographs, P = .004). Qualitative ratings of both traditional and 3D images showed high inter- and intrarater reliability between experts and nonexperts alike. Physicians’ Global Assessment of Damage scores correlated with mouth asymmetry (P = .0021), cheek asymmetry (P = .04), and 3D-stereophotogrammetry ratings (median, mild: 27.5 vs moderate: 46.5 vs severe: 64, P = .0152). Lower face asymmetry correlated with worse quality-of-life scores (P = .013). Limitations: Small sample size and cross-sectional design. Conclusion: 3D stereophotogrammetry can reliably detect and quantify asymmetry in craniofacial morphea with greater sensitivity than that observed with traditional assessment alone. 3D stereophotogrammetry may be a useful adjunct to clinical examination.
AB - Background: Objectively determining tissue loss in craniofacial morphea is challenging. However, 3-dimensional (3D) stereophotogrammetry is a noninvasive modality that may be a useful adjunct. Objective: To prospectively evaluate 3D stereophotogrammetry in the assessment of craniofacial linear morphea. Methods: Participants underwent clinical, quality-of-life, and 3D-stereophotogrammetry assessments. Traditional photographs and 3D-stereophotogrammetry images were rated as mild, moderate, or severe by 2 experts and 2 nonexperts. In addition, interrater and intrarater reliability (on delayed rescoring) were calculated. Results: Of 23 patients with craniofacial morphea, 3D stereophotogrammetry detected pathologic asymmetry in 14 (20.6%) patients. Providers rated patients as more severely affected when using 3D stereophotogrammetry versus when using traditional photographs (19% severe on 3D stereophotogrammetry vs 0% severe on traditional photographs, P = .004). Qualitative ratings of both traditional and 3D images showed high inter- and intrarater reliability between experts and nonexperts alike. Physicians’ Global Assessment of Damage scores correlated with mouth asymmetry (P = .0021), cheek asymmetry (P = .04), and 3D-stereophotogrammetry ratings (median, mild: 27.5 vs moderate: 46.5 vs severe: 64, P = .0152). Lower face asymmetry correlated with worse quality-of-life scores (P = .013). Limitations: Small sample size and cross-sectional design. Conclusion: 3D stereophotogrammetry can reliably detect and quantify asymmetry in craniofacial morphea with greater sensitivity than that observed with traditional assessment alone. 3D stereophotogrammetry may be a useful adjunct to clinical examination.
KW - 3D-stereophotogrammetry
KW - craniofacial morphea
KW - imaging
KW - localized scleroderma
KW - morphea
KW - morphea en coup de sabre
KW - Parry Romberg syndrome
KW - rheumatologic dermatology
UR - http://www.scopus.com/inward/record.url?scp=85143275549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143275549&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2022.05.029
DO - 10.1016/j.jaad.2022.05.029
M3 - Article
C2 - 35643243
AN - SCOPUS:85143275549
SN - 0190-9622
VL - 88
SP - 101
EP - 108
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 1
ER -